Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Scientific Health Development (SHD) is a venture capital firm founded in 2006 and headquartered in Dallas, Texas. The firm focuses on early-stage investments in medical technology (medtech) companies that address unmet clinical needs in the healthcare sector. SHD has made over 20 investments to date, primarily in the United States, and leverages Qualified Small Business (QSBS) tax advantages to enhance the appeal of its investments for limited partners.
Over the years, SHD has established itself as a key player in the medtech investment space, particularly noted for its strategic focus on technologies that improve patient outcomes while minimizing economic burdens. The firm has a history of collaborating with co-investors such as InCube Ventures and Boston Scientific, which further strengthens its portfolio and investment strategy.
SHD's office is located at 8144 Walnut Hill Lane, Suite 905, Dallas, TX 75231. The firm continues to actively engage with industry trends and portfolio advancements, showcasing its commitment to supporting innovative healthcare solutions.
Scientific Health Development specializes in early-stage investments in the healthcare and biotech sectors, particularly in medical technology. The firm targets companies at the pre-seed, seed, seed+, Series A, and Series A+ stages, with check sizes ranging from $10 million to $50 million. SHD seeks to invest in innovative medical technologies that require smaller amounts of funding and have attainable, near-term value inflection points leading to potential exits.
SHD emphasizes the importance of easily adoptable technologies that can significantly improve patient outcomes while reducing economic burdens. The firm looks for companies that are developing solutions to address unmet clinical needs, ensuring that their investments align with its mission to enhance healthcare delivery. This focus on early-stage medtech allows SHD to identify and support startups that are poised for growth and success in the competitive healthcare landscape.
Scientific Health Development has built a diverse portfolio of innovative companies in the medical technology sector. Notable portfolio companies include:
This portfolio reflects SHD's commitment to supporting companies that are at the forefront of medical innovation, addressing critical healthcare challenges.
Andrew Offer, CFA: CEO and General Partner. Andrew has extensive experience in venture capital and healthcare investments, having led numerous successful funding rounds in the medtech sector.
Phil Romano: Co-founder and General Partner. Phil brings a wealth of knowledge in entrepreneurship and investment, with a focus on innovative healthcare solutions.
Stuart Fitts: Co-founder and General Partner. Stuart has a strong background in medical technology and has been instrumental in shaping SHD's investment strategy.
Mike Schotzinger, PhD: Principal. Mike specializes in the scientific and technical aspects of medical devices, providing valuable insights into the evaluation of potential investments.
To pitch Scientific Health Development, founders should send an email to info@shdpartners.com. A well-structured pitch deck is essential, including details about the business model, market opportunity, and technology. SHD prefers to see clear value propositions and attainable milestones in the pitch.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions through mutual connections in the medtech industry can enhance the chances of a successful pitch.
In 2026, Scientific Health Development has been actively promoting its portfolio companies through blog posts highlighting significant developments. Notable mentions include Medicaid coverage expansions for scalp cooling technology provided by Cooler Heads and FDA approvals for various medical devices within its portfolio.
Additionally, SHD co-led a $20.3 million Series A-3 funding round for Mindera Health alongside Mountain Group Partners and Rockmont Investments, showcasing its commitment to supporting innovative healthcare solutions.
What are the investment criteria for Scientific Health Development?
SHD invests in early-stage medical technology companies that address unmet clinical needs. The firm focuses on easily adoptable technologies that improve patient outcomes while minimizing economic burdens.
How can I pitch my startup to SHD?
Founders can reach out via email at info@shdpartners.com. It is advisable to include a detailed pitch deck outlining the business model, market opportunity, and technology.
What makes SHD different from other venture capital firms?
SHD specializes in early-stage investments in medtech, leveraging QSBS tax advantages for its limited partners and focusing on technologies with attainable near-term value inflection points.
What is the geographic focus of SHD?
The firm primarily invests in companies based in the United States, particularly those developing innovative healthcare solutions.
What is the typical check size for investments?
SHD typically invests between $10 million and $50 million in its portfolio companies, depending on the stage and needs of the startup.
What kind of support does SHD provide to its portfolio companies?
SHD adds value through strategic guidance, access to a network of industry contacts, and assistance in achieving near-term value inflection points, enhancing the potential for successful exits.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.